Nicole Fried
Papers
1
Total Citations
124
H-Index
1
About
Nicole Fried is a pioneering researcher in the field of three-dimensional (3-D) cell culture technology, with a primary focus on advancing automated production and drug sensitivity testing for biomedical applications. Her landmark 2011 paper, "Towards automated production and drug sensitivity testing using scaffold‐free spherical tumor microtissues," has garnered 124 citations, underscoring its foundational impact on bridging the gap between academic 3-D culture research and industrial implementation. Fried’s major contribution lies in developing reliable high-throughput methodologies that enable the scalable production of scaffold-free spherical tumor microtissues, addressing a critical bottleneck in translating 3-D culture systems from laboratory settings to commercial drug testing platforms. Her work has been instrumental in demonstrating the practical feasibility of automated systems for generating consistent, physiologically relevant microtissues, which are essential for more accurate drug efficacy and toxicity assessments. By tackling the slow industrial adoption of 3-D culture, Fried has helped pave the way for more efficient and reproducible preclinical testing, directly influencing cancer research and pharmaceutical development. Her achievements highlight a commitment to innovation in tissue engineering and assay automation, making her a notable figure in the evolution of high-throughput drug screening technologies.
Research Focus
Key Achievements
Top Papers
- 1